OM vs. ZYXI, AXGN, EDAP, SMLR, ELMD, FONR, VANI, HYPR, ECOR, and CUTR
Should you be buying Outset Medical stock or one of its competitors? The main competitors of Outset Medical include Zynex (ZYXI), AxoGen (AXGN), Edap Tms (EDAP), Semler Scientific (SMLR), Electromed (ELMD), FONAR (FONR), Vivani Medical (VANI), Hyperfine (HYPR), electroCore (ECOR), and Cutera (CUTR). These companies are all part of the "electromedical equipment" industry.
Zynex (NASDAQ:ZYXI) and Outset Medical (NASDAQ:OM) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, profitability, dividends, valuation, community ranking, media sentiment, analyst recommendations and institutional ownership.
Zynex presently has a consensus target price of $18.00, indicating a potential upside of 77.34%. Outset Medical has a consensus target price of $5.42, indicating a potential upside of 45.22%. Given Outset Medical's stronger consensus rating and higher probable upside, analysts plainly believe Zynex is more favorable than Outset Medical.
29.7% of Zynex shares are held by institutional investors. 52.1% of Zynex shares are held by company insiders. Comparatively, 3.5% of Outset Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Zynex has a net margin of 4.33% compared to Zynex's net margin of -134.93%. Outset Medical's return on equity of 16.34% beat Zynex's return on equity.
Zynex and Outset Medical both received 22 outperform votes by MarketBeat users. However, 51.16% of users gave Zynex an outperform vote while only 37.93% of users gave Outset Medical an outperform vote.
In the previous week, Zynex and Zynex both had 1 articles in the media. Outset Medical's average media sentiment score of 1.44 beat Zynex's score of 1.38 indicating that Zynex is being referred to more favorably in the media.
Zynex has higher revenue and earnings than Outset Medical. Outset Medical is trading at a lower price-to-earnings ratio than Zynex, indicating that it is currently the more affordable of the two stocks.
Zynex has a beta of 0.49, suggesting that its stock price is 51% less volatile than the S&P 500. Comparatively, Outset Medical has a beta of 1.85, suggesting that its stock price is 85% more volatile than the S&P 500.
Summary
Zynex beats Outset Medical on 14 of the 16 factors compared between the two stocks.
Get Outset Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for OM and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding OM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Outset Medical Competitors List
Related Companies and Tools
